Wednesday Morning Oncology Journal Club
3455 321
7:30-8:30 AM
CHOMP
Medical Staff Conference Room #1
Dec 2025
Dec 3 ESR1 in Breast Cancer: Imlunestrant
“Imlunestrant with or without Abemaciclib in Advanced Breast Cancer”
Jhaveri K, Neven P, Casalnuoco M, et al. NEJM March 27th, 2025
-Nancy Rubin
Dec 10 ESR1 in Breast Cancer: Treat early or …. not ?
“First Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer”
Bidard F-C, Mayer E, Park YH et al. NEJM August 7th, 2025
-John Hausdorff
Dec 17 PROTAC: Degradation is the new reality
“Vepdegestrant, a PROTAC Estrogen Receptor Degrader in Advanced Breast Cancer”
Campone M, De Laurentiis M., Komal Jhaveri, K et al. NEJM August 7th, 2025
“Science behind the Study: Degradation of the Estrogen Receptor in Breast Cancer”
D.P. McDonnell. NEJM August 7th, 2025
-Ron Garren
Dec 24 Holiday
Dec 31 Holiday
